A. Cell therapy |
Example: Deliver a cell such as mesenchymal stem cell, multipotent adult progenitor cell, or umbilical cord stem cell intravenously or by stereotactic injection into the brain in stroke; transplantation of olfactory ensheathing cell in spinal cord injury |
B. Combination of cell and gene therapy |
Example: Transplantation of neural stem cell expressing transgene such as glial‐derived neurotrophic factor for Parkinson's disease |
C. Enhance endogenous neurogenesis and repair |
Examples: Erythropoietin, granulocyte stimulating factor (G‐CSF), brain‐derived neurotrophic factor in stroke; use of dopamine D3 agonists in Parkinson's disease |
D. Allogeneic stem cell transplantation |
Example: Unrelated human umbilical cord transplant in Krabbe's disease, Hurler's disease |
E. Autologous hemtopoietic stem cell transplantation |
Example: Autologous HSCT in patients with early multiple sclerosis |
F. Inhibiting myelin‐associated inhibitors of axonal regeneration |
Example: Nogo inhibitors in stroke, spinal cord injury |